This brand name is authorized in France, Tunisia, Turkey
The drug URSOLVAN contains one active pharmaceutical ingredient (API):
|
1
Ursodeoxycholic acid
UNII 724L30Y2QR - URSODIOL
|
|
The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A05AA02 | Ursodeoxycholic acid | A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AA Bile acid preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 66830922 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 16363011 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699569011019 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
